Enclave Advisors LLC Eli Lilly & CO Transaction History
Enclave Advisors LLC
- $590 Billion
- Q3 2024
A detailed history of Enclave Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Enclave Advisors LLC holds 380 shares of LLY stock, worth $298,767. This represents 0.06% of its overall portfolio holdings.
Number of Shares
380Holding current value
$298,767% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
3,965Shares Held
751MCall Options Held
6.32MPut Options Held
8.66M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$76.2 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$58 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$51.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$40.4 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$26.6 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $747B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...